The gold standard antimicrobial, vancomycin, has several shortcomings that have prompted the development of newer agents for the treatment of MRSA disease ... from common skin infections such ...

Hospital acquired (HA)-MRSA and community acquired ... in the initiation and progression of infections via direct tissue damage to mucosal membranes and skin. Protein-synthesis inhibition is ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

Basilea will seek approval of ceftobiprole for SAB as well as acute bacterial skin ... treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA ...

2, 2025 — A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment ... skin that are targeted by EBOV during infection ...

Warts: Diagnosis and treatment. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Skin diseases. MedlinePlus. Skin infections. American College of Allergy, Asthma ...

NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...

Even fit and healthy people can be unlucky enough to pick up superbug infections, including athletes, with NFL players reporting MRSA skin infections ... new preventative treatments, but there ...